Kaur et al. [248] found that inhibition of the AT1 receptor shows promise in reducing IL-1β-driven inflammation, extracellular matrix (ECM) breakdown, and chondrocyte death in osteoarthritis, while also promoting ECM production, autophagy, and protection of cartilage cells. This evidence concerns the gene AGTR1 and osteoarthritis.